Globus Medical Plans Q4 2024 Earnings Release February 20, 2025

Globus Medical, Inc. announced it will release its financial results for the fourth quarter and full-year ending December 31, 2024, on February 20, 2025, followed by a teleconference at 4:30 p.m. Eastern Time to discuss performance with investors. Concurrently, Roth Capital has revised its earnings per share estimate for the company for FY2024 from $3.03 to $3.00, while the consensus estimate stands at $2.98. In addition, several analysts have upgraded their target prices for Globus Medical, reflecting positive expectations for the company's stock performance. Piper Sandler, Canaccord Genuity, and Morgan Stanley have all increased their price targets significantly, with the consensus price target now at $96.91. Analysts have generally rated the stock as a 'Moderate Buy,' indicating strong market confidence in its future prospects. Overall, Globus Medical continues to demonstrate growth potential amidst analyst scrutiny and market evaluations.